| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 09/16/2009 | CN101531567A Method for synthesizing beta, gamma-polysubstituted beta, gamma-unsaturated alcohol |
| 09/16/2009 | CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589127 Aminoalkylphenols, methods of using and making the same |
| 09/15/2009 | US7589120 N-[[4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-thienyl]methyl]-4-(trifluoromethyl)benzenesulfonamide; antagonist properties with regard to CB1 cannabinoid receptors |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589089 Inhibitors for GlyT-1 |
| 09/11/2009 | WO2009111322A1 Substituted cyclopentanes having prostaglandin activity |
| 09/11/2009 | WO2009110520A1 Heterocyclic compound |
| 09/11/2009 | WO2009110217A1 Hydroxyapatite with silver supported on the surface thereof |
| 09/11/2009 | WO2009109992A1 Novel process for preparation of duloxetine and intermediates for use therein |
| 09/11/2009 | WO2009109483A1 Leukotriene b4 inhibitors |
| 09/11/2009 | WO2009048152A3 Unsaturated imine compound and use thereof for pest control |
| 09/11/2009 | WO2009021126A9 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 09/11/2009 | WO2009002730A3 High shear process for the production of butadiene sulfone |
| 09/11/2009 | CA2717202A1 Leukotriene b4 inhibitors |
| 09/11/2009 | CA2717138A1 Heterocyclic compound |
| 09/11/2009 | CA2625306A1 Electron acceptors-cored regioregular oligothiophenes as building blocks for soluble low band-gap conjugated polymers |
| 09/10/2009 | US20090227748 Process for Preparing Olff in Polymers in the Presence of Catalyst Systems Having Photochromic Groups |
| 09/10/2009 | US20090227667 5'-chloro-N-[3,3,3-trifluoro-2-(trifluoromethyl)-1S-(hydroxymethyl)propyl]thiophene-2'-sulfonamide, used for the treatment of Alzheimer's Disease and Down's syndrome |
| 09/10/2009 | US20090227625 Cxcr2 inhibitors |
| 09/10/2009 | US20090227603 Leukotriene b4 inhibitors |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227573 Substituted cyclopentanes having prostaglandin activity |
| 09/10/2009 | US20090226634 Synthesis and applications of soluble pentacene precursors and related compounds |
| 09/09/2009 | EP2098120A2 2-alkyl-cycloalk(en) yl-carboxamides |
| 09/09/2009 | EP2097395A1 Process for the preparation of valsartan and intermediate products |
| 09/09/2009 | EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 09/09/2009 | EP1881958B1 Diacylglycerol acyltransferase inhibitors |
| 09/09/2009 | EP1567477B1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/09/2009 | CN101528726A Thiophene derivatives as S1P1/EDG1 receptor agonists |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585977 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585574 Pyrene derivative and organic electroluminescence device making use of the same |
| 09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
| 09/08/2009 | CA2373665C Substituted thienocycloalk(en)ylamino-1,3,5-triazine |
| 09/08/2009 | CA2366820C Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments |
| 09/03/2009 | WO2009107799A1 Process for production of thiophene compound and intermediate thereof |
| 09/03/2009 | US20090221832 Process for preparing ketones from alpha-oxo carboxylates and aryl bromides |
| 09/03/2009 | US20090221669 Disubstituted Aniline Compounds |
| 09/03/2009 | US20090221668 Synthesis and preparations of duloxetine salts |
| 09/03/2009 | US20090221654 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 09/03/2009 | US20090221572 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/03/2009 | US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease |
| 09/03/2009 | US20090220886 Polyhydric compound and chemically amplified resist composition containing the same |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | CA2717065A1 Process for producing thiophene compound and intermediate thereof |
| 09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
| 09/02/2009 | EP2096101A1 Method for producing ketones from alpha-oxocarboxylates and aryl bromides |
| 09/02/2009 | CN101519410A Preparation method for metallic thiophene ring ternary complex with anti-cancer activity and application thereof |
| 09/02/2009 | CN101519401A Intermediate (S)-2-(2-thiophene ethylamine)(2-chlorphenyl)methyl acetate of clopidogrel and method for preparing salts thereof |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/01/2009 | US7582782 Organic compounds |
| 09/01/2009 | US7582776 Using 3-hydroxy-3(2-thiophenyl)-N-methylpropionamide; chemical intermediate for fluoxetine |
| 09/01/2009 | US7582775 Vitamin D receptor modulators |
| 09/01/2009 | US7582766 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; (N-benzyl)phenylacetamides or N-benzyl-N'-phenyl ureas |
| 09/01/2009 | US7582673 Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | US7582589 3-carbonylaminothiophenes and their use as fungicides |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 08/27/2009 | WO2009104733A1 Organic electroluminescent device material and organic electroluminescent device |
| 08/27/2009 | WO2009103440A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/27/2009 | US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/27/2009 | US20090215829 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
| 08/27/2009 | US20090215623 Insecticidal 3-acylaminobenzanilides |
| 08/27/2009 | US20090214631 Process for the Preparation of Strontium Ranelate |
| 08/27/2009 | CA2714654A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2091527A2 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | CN101516837A Sulfonamide derivatives |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101514196A Thiophene derivative and application thereof |
| 08/26/2009 | CN101514173A Polyhydric compound and chemically amplified resist composition containing the same |
| 08/26/2009 | CN101514141A Synthetic method for allyl alcohol-like compound |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |
| 08/25/2009 | US7579484 Method for the production of monoalkylamino ketones |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579346 Carboxamides |
| 08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/20/2009 | WO2009102034A1 Method for producing fluoro-compound |
| 08/20/2009 | WO2009101823A1 Branched compounds, organic thin films made by using the same, and organic thin film devices |
| 08/20/2009 | WO2009029317A3 Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
| 08/20/2009 | US20090209617 Duloxetine salts |
| 08/20/2009 | US20090209588 Novel compounds, their preparation and use |
| 08/20/2009 | US20090209532 Pharmaceutical compounds |
| 08/19/2009 | EP2090566A2 Certain phenylacetic acids and derivatives |
| 08/19/2009 | EP2090309A1 Use of thiazole inhibitors of fatty acid oxidation of formula (I) for the treatment of Alzheimer's disease and other neurological conditions |